Blood group A tetrasaccharides are carbohydrate structures specific to the A antigen in the ABO blood group system, extending the core trisaccharide by an additional sugar unit and playing key roles in immune recognition and serological activity. These tetrasaccharides inhibit anti-A antibody binding and are found in various biological sources, including milk samples. They differ from the minimal A trisaccharide, which consists of a branched Gal-β with α-Fuc at O-2 and α-GalNAc at O-3.

Structural Diversity

Blood group A tetrasaccharides exist in multiple types, such as type 1, type 2, and type 5, defined by the core chain linkage. Type 5 A-tetrasaccharide, isolated from polar bear milk, exemplifies a blood group-specific oligosaccharide with potent inhibition of anti-A antibodies. Type 1 and type 2 variants feature distinct Gal-GalNAc linkages, influencing antigen presentation on red blood cells.

Biological Significance

These tetrasaccharides modulate sialic acid recognition on red blood cells and serve as synthetic antigens for antibody removal in transplantation. High molecular weight conjugates with polyacrylamide enhance their utility in immunoadsorption devices for mitigating hyperacute rejection in ABO-incompatible procedures. Serologically active forms derived from glycoproteins further confirm their essential role in blood compatibility.

Synthesis Approaches

Chemical synthesis targets spacered or biotinylated derivatives using stereoselective glycosylation with azido-galactosamine donors and fucosyl blocks for α-linkages. Enzymatic methods replicate natural gene-specified structures, producing products identical to those found in biological systems. These strategies enable the generation of neoglycolipids and glycoconjugates for research and biotechnological applications.